Lilac Agriculture Closes Oversubscribed $2.3 Million Series Seed to Advance Next-Generation Rhizobium Inoculants for Pulse Growers

Tall Grass Ventures is proud to announce our investment in Lilac Agriculture as part of its oversubscribed $2.3 million Series Seed financing round.

FARGO, N.D. — September 22, 2026 Lilac Agriculture, a company bringing modern biological innovation to rhizobial strains farmers already rely on, today announced the close of an oversubscribed $2.3 million Series Seed financing. Innova led the round, which was targeted at $1.5 million and closed more than 50 percent above that figure. 701 Fund, Ag Ventures Alliance, Evergreen Climate Innovations, North Dakota Development Fund, Pathway Ventures, Tall Grass Ventures, and others also participated.


“This is Innova’s first investment in agricultural biologicals, and we didn’t make it lightly - we’ve looked hard at this category. We like that Lilac brings biological innovation to strains farmers already know and use, applying modern science in a practical way that doesn’t ask farmers to take on unproven risk. That, paired with a product already in growers’ hands and a platform with a credible path beyond pulses into other row crops, is exactly the kind of business we wanted to back, said Dean Didato, Partner at Innova.


Peas, lentils, and dry beans fix their own nitrogen through a symbiosis with rhizobia, the soil bacteria that colonize their roots, and inoculating seed with those bacteria each spring is standard practice for pulse growers. The persistent challenge is competitiveness: native rhizobial populations already established in the soil often out-compete the strains in the purchased inoculant for nodule occupancy, resulting in limited and inconsistent yield benefit.


Lilac’s Guided Adaptation platform is built to optimize two traits at once - nitrogen-fixing efficiency and competitiveness. Applying plant-breeding logic to the microbe, Lilac starts with a broad diversity of rhizobial strains licensed on an exclusive basis from North Dakota State University and systematically improves them for the specific soils where they’ll be used. An elite strain that fixes more nitrogen and holds the nodule against native competition can support higher yield potential and reduce reliance on costly synthetic fertilizer. Lilac is starting in pulses, but the same platform is designed to extend to other crops, including row crops, over time.


“A better strain doesn’t help a grower if it can’t win the nodule in their own soil - that’s the gap we built Lilac to close,  ” said Dr. Natalie DiNicola, CEO of Lilac Agriculture. “Growers have relied on inoculants for generations, but rarely with real visibility into how they’re performing in their own fields. This round funds our expanded field trial and R&D pipeline, gets PL11 into more farmers’ hands across the region, and supports preparation for the Canadian market.”


“Having grown up as a farmer, the black-box claims in this category always frustrated me - you put an inoculant in the ground and just have to trust that it works. As a scientist, I want to fix that. There’s a huge amount of untapped variation in rhizobial bacteria that’s gone largely unexplored since most commercial strains were selected decades ago. Adapting strains to the crop and soil they’ll actually encounter, and measuring nodulation that happens in the field, is how we aim to deliver the efficacy and consistency growers are asking for,” said Dr. Barney Geddes, Chief Scientific Officer at Lilac Agriculture, who grew up farming before building his career as a global rhizobium expert with an extensive lab at NDSU.


Lilac’s lead product, PL11, is already on the ground with pea and lentil growers across the Northern Plains. Early trial results have shown strong strain colonization at multiple sites, and expanded field trials are underway to validate performance more broadly ahead of the next commercial season. Registration is also underway for the Canadian market, as Canada is the world’s largest producer and exporter of both peas and lentils.


About Lilac Agriculture

Lilac Agriculture is applying modern biological innovation to deliver the next generation of rhizobium inoculants. Founded by a farmer-turned-scientist and built on research developed at North Dakota State University, Lilac’s Guided Adaptation platform selects and adapts rhizobial strains to fix more nitrogen and outcompete native soil populations in the fields where they’re actually used. The company is starting with peas, lentils, and dry beans across the Northern Plains, with a platform designed to extend to other row crops over time. Lilac is headquartered in Fargo, North Dakota. Learn more at www.lilac.ag.

By Connie Wiltshire June 15, 2026
Canadian startup helps farmers optimize fertilizer applications and expands its real-time crop nutrition platform to soy and wheat.
By Connie Wiltshire September 23, 2025
Sensor Globe closes Pre-Seed round to scale sustainable aquaculture tech!
By Connie Wiltshire September 8, 2025
Tall Grass Ventures and Accelerate Fund IV co-lead investment to expand predictive storage monitoring across North America
By Connie Wiltshire July 24, 2025
EmGenisys Completes Oversubscribed $1.5 Million Raise from Leading VCs to Transform Livestock Reproduction with Artificial Intelligence
By Connie Wiltshire December 12, 2024
Danish AgriRobot Secures Investment for Robot Safety Software
By Connie Wiltshire July 22, 2024
PheroSyn Secures Funding from Tall Grass Ventures to Advance Sustainable Pest Management Solutions
July 4, 2024
Tall Grass Ventures Announces Oversubscribed Final Close
June 3, 2024
IntelliCulture Raises $3.5M to Double Down on Growth
January 31, 2024
Tall Grass Welcomes Farm Credit Canada
By Marlise Hunter January 9, 2024
January 9, 2024 – GeneNeer Ltd. is pleased to announce it has successfully closed a US$1 million seed round to support the acceleration of its technology for rapid crop seed innovation. The company’s breakthrough method leverages its proprietary Superlines and tissue-specific silencing capabilities to improve the current precision, speed and safety of advanced breeding technologies. In a league of its own, GeneNeer is positioned to democratize crop seed innovation, fostering more rapid, localized solutions to impacts of climate change, and to accelerate the development of healthier, more functional natural food sources. The funding round was led by Tall Grass Ventures, an early-stage Agrifood Tech venture firm based in Canada, and 2b AHEAD Ventures, a repeat investor from Germany. The funds will be used to expand the company’s research and development into its methods for enhancing gene editing and gene discovery. While the company’s first focus is on the potato market, further development in other key crops is being actively pursued through strategic partnerships. Chris Edwards, Managing Partner at Tall Grass Ventures, said “We believe GeneNeer is at the forefront of gene-editing in crop development through their novel and proprietary Superline technology. With this technology, they have developed a multi-faceted platform, which we believe mitigates many of the business risks inherent in biotechnology and deep science-based startups. This approach not only enhances stability, but also aligns with the nimbleness and adaptability required to lead an emerging field. “GeneNeer’s commitment to success is further reinforced by the exceptional quality of their team. With a deep mix of technical competency, skill and business acumen, the team is well positioned to successfully execute against their vision and have a significant role in increasing the resilience and adaptability of global agriculture,” added Edwards. The investment is the climax of a successful year, marked by multiple successful proof of concept trials, a paid collaboration with a Tier-1 company; participation in the prestigious StartLife program for promising agritech start-ups; the registration of a second patent application; and significant strides in its research and development activities. As a result, the company doubled its valuation in 2023. Kinneret Shefer PhD, CEO and Co-founder of GeneNeer said, “The addition of Tall Grass Ventures and return investment of 2b AHEAD Ventures provide GeneNeer with outstanding support from seasoned, savvy and visionary investors and mentors. Their involvement will be instrumental in GeneNeer’s ability to achieve its ambitious business plans.” Sven Gabor Janszky, CEO of 2b AHEAD Ventures and Chairman of Europe’s largest Future Science Institute 2b AHEAD said, “We are proud to continuously support GeneNeer’s progress to solve one of the world’s biggest challenges: to provide food security for up to 11 billion people on Earth in times of global warming. Even for us, with a portfolio of 30+ deeptech investments worldwide – from Nuclear Fusion to Quantum Computing – GeneNeer is outstanding in its product vision and the excellence of its technological platform.” About GeneNeer: GeneNeer is engaged in the enhancement of crops through the development of innovative methods for expedited precisely-controlled gene editing and rapid gene discovery, using its patent-protected Superlines and tissue-specific silencing. The company aims to use its capabilities to support global food security and nutrition. GeneNeer is a member of the prestigious StartLife program for promising startups. www.geneneer.com
More Posts